Hirsutism, Hair Loss, and Hormonal Hair Disorders: Causes, Diagnosis, and Treatments
Unwanted facial or body hair and scalp hair loss can occur together, but the pattern determines the workup. Hirsutism concerns coarse hair at androgen-sensitive sites in women. Gradual scalp thinning, sudden diffuse shedding and smooth bald patches point toward different conditions and treatments. [13,2]
Begin with where the change occurred, how quickly it developed and whether periods, medicines or general health changed at the same time. Photographs taken in similar lighting can help document the course.
How do the main patterns differ?
| Pattern | Condition to assess | What helps clarify it |
|---|---|---|
| Coarse hair on the chin, upper lip, chest or abdomen | Hirsutism | Distribution, menstrual history, progression and androgen assessment when indicated |
| Gradual crown thinning or a widening part | Pattern hair loss | Scalp examination and comparison with earlier photographs |
| Increased shedding across the scalp after illness, childbirth or weight change | Telogen effluvium | Trigger timeline and assessment for thyroid or nutritional contributors |
| Smooth round or oval bald patches | Alopecia areata | Dermatology examination, including other hair-bearing areas and nails |
These patterns can overlap. A person may have both pattern hair loss and a period of increased shedding. [2,3,4]
How is hirsutism assessed?
The modified Ferriman-Gallwey score rates terminal hair across body regions. The 2023 international PCOS guideline recommends a threshold around 4 to 6 depending on ethnicity, rather than treating 8 as a universal cutoff. Hair removal can hide the findings, so describe the untreated pattern and how often you remove hair. [5]
The Endocrine Society recommends androgen testing for an abnormal hirsutism score. Isolated unwanted local hair in someone with regular cycles and no abnormal score does not automatically require a broad hormone panel. Further testing depends on the presentation, including menstrual disturbance or progression. [1]
Hypertrichosis is a different pattern of excess hair that is not necessarily androgen driven. Medication history is particularly useful because some hair-growth treatments can increase hair elsewhere on the body. [13,9]
Rapid progression or new virilizing changes, such as a deeper voice, calls for prompt evaluation. A 2025 report described two postmenopausal patients with markedly elevated testosterone and ovarian pathology despite unrevealing or inconclusive imaging. The cases support continued specialist investigation when the clinical findings and imaging disagree; they do not establish a routine surgical pathway for hirsutism. [7]
What treatments help unwanted facial and body hair?
For hirsutism that remains bothersome despite cosmetic measures, combined oral contraceptives are a common initial treatment when pregnancy is not being sought. An antiandrogen can be added if the response is insufficient after six months. The Endocrine Society does not identify one contraceptive as universally more effective for hair reduction. [1]
Spironolactone can reduce androgen-related facial and body hair and may also help some types of scalp thinning. Results take months. Potassium monitoring depends on age, kidney or heart conditions and other medicines; a monthly testing schedule is not a rule for every dermatology patient. [6]
Antiandrogen treatment requires attention to pregnancy prevention when pregnancy is possible. Discuss the plan before starting, rather than assuming an acne or hair prescription fits every reproductive situation. [13]
Metformin addresses metabolic and reproductive aspects of PCOS. The Endocrine Society recommends against using insulin-lowering medicines solely to treat hirsutism. [1]
Which hair-removal method fits the hair and skin?
Laser or other photoepilation methods are useful for pigmented hair, while electrolysis can treat white or blond hair. The device and settings should be selected for skin tone. [1]
Eflornithine cream, where available, can slow facial hair growth and can accompany direct hair removal. It does not remove an existing hair immediately. [13]
Ask the treating clinic about the expected number of sessions, maintenance, the method's suitability for your hair color, and how it will assess progress. Hair removal and treatment of the hormonal cause answer different parts of the problem.
How is pattern scalp hair loss treated?
Topical minoxidil is a main option for male and female pattern hair loss. Finasteride is a prescription option for male pattern hair loss. Treatment usually needs to continue to maintain the benefit. Finasteride's sexual side effects and pregnancy-related restrictions belong in the prescribing discussion. [2,8]
Oral minoxidil is also prescribed for hair loss. A 2024 randomized trial enrolled 90 men and compared 5 mg daily orally with 5% topical minoxidil twice daily for 24 weeks. Oral treatment did not demonstrate superiority on the principal hair-density comparisons. Unwanted body hair and headache were common oral-treatment effects. The trial does not establish that everyone should switch from topical treatment. [9]
Women with scalp thinning and hirsutism may need both dermatologic and hormonal assessment. A widening part alone does not prove elevated blood androgens. Spironolactone may be considered according to the pattern and medical history. [5,6]
Procedures such as platelet-rich plasma may be discussed separately. Ask which outcome the clinic measures and how the proposed schedule compares with the medication plan, rather than treating all regrowth procedures as interchangeable. [2]
What helps diffuse shedding after a trigger?
Telogen effluvium often begins a few months after a triggering event. The shedding phase commonly lasts three to six months, while recovery of visible thickness takes longer. Assessment can include thyroid or iron testing when the history suggests it. [3]
Correcting an identified trigger or deficiency is the central step. A hair-loss diagnosis alone does not set a ferritin target. Supplements are most useful when the evaluation identifies a nutritional need. [2,3]
People using GLP-1 medicines can experience shedding during weight loss, but a direct medication contribution is also being studied. Review nutrition, the rate of weight change and the scalp pattern instead of assuming all hair loss has one explanation. [10]
Tell the clinician about biotin supplements before blood tests. Biotin can interfere with certain assays, including troponin tests. [11]
How does alopecia areata treatment differ?
Alopecia areata involves immune activity around hair follicles. Limited patches may be treated with corticosteroid injections or topical treatments. More extensive disease introduces other options, with treatment selected according to age, extent and the person's health. [4]
Current approved oral options include baricitinib and deuruxolitinib for adults with severe alopecia areata, and ritlecitinib for patients aged 12 or older with severe disease. Deuruxolitinib received FDA approval in July 2024. [4,12]
These medicines require their own assessment and monitoring, including the infection and clotting considerations described in their prescribing information. A dermatologist can explain which option fits the diagnosis. [12]
What makes a useful follow-up visit?
Choose a measure that matches the problem: frequency of facial-hair removal, photographs of the scalp part, shedding duration or extent of bald patches. Keep the treatment start date and actual use alongside the photographs.
Bring menstrual changes, new medicines and any unusually rapid progression into the discussion. The goal is a diagnosis-specific plan with enough time to assess the intended response, rather than repeatedly changing products before the hair cycle can show a difference.
References
- Endocrine Society. Evaluation and treatment of hirsutism in premenopausal women: clinical practice guideline. 2018.
- American Academy of Dermatology. Hair loss: diagnosis and treatment.
- British Association of Dermatologists. Telogen effluvium.
- American Academy of Dermatology. Alopecia areata: diagnosis and treatment.
- Teede HJ, et al. International evidence-based PCOS guideline recommendations. 2023.
- British Association of Dermatologists. Spironolactone.
- Indication for diagnostic oophorectomy without radiographic evidence: two postmenopausal cases. 2025.
- DailyMed. Propecia prescribing information.
- Penha MA, et al. Oral versus topical minoxidil for male androgenetic alopecia: randomized trial. JAMA Dermatology. 2024.
- American Academy of Dermatology. GLP-1 drugs and effects on skin, hair and nails.
- FDA. Biotin interference with troponin laboratory tests.
- FDA. Leqselvi drug trials snapshot and prescribing information.
- British Association of Dermatologists. Hirsutism.